Prader-Willi syndrome
Recent articles
Oxytocin lessons from autism-linked syndromes: A chat with Christian Schaaf and Ferdinand Althammer
Oxytocin therapies have failed to consistently benefit autistic people, but their effects in people with two autism-linked conditions may yield new insights, experts argue.
Oxytocin lessons from autism-linked syndromes: A chat with Christian Schaaf and Ferdinand Althammer
Oxytocin therapies have failed to consistently benefit autistic people, but their effects in people with two autism-linked conditions may yield new insights, experts argue.
Dispatches from SfN 2021: Mitochondria, Rett therapy and oxytocin
These short reports from Spectrum journalists highlight some of the autism-related findings that caught our attention at the meeting this past week.
Dispatches from SfN 2021: Mitochondria, Rett therapy and oxytocin
These short reports from Spectrum journalists highlight some of the autism-related findings that caught our attention at the meeting this past week.
The push to screen newborns for rare autism-linked genetic conditions
As treatments for some autism-linked genetic conditions inch closer to the clinic, researchers are talking more urgently about screening all newborns for such conditions.
The push to screen newborns for rare autism-linked genetic conditions
As treatments for some autism-linked genetic conditions inch closer to the clinic, researchers are talking more urgently about screening all newborns for such conditions.
How to safeguard online data collection against fraud
When autism researcher Clare Harrop tried to recruit survey participants over social media, she received hundreds of fraudulent responses. But there are ways researchers can protect themselves from similar experiences.
How to safeguard online data collection against fraud
When autism researcher Clare Harrop tried to recruit survey participants over social media, she received hundreds of fraudulent responses. But there are ways researchers can protect themselves from similar experiences.
Vasopressin relieves social deficits in an autism mouse model
Mice missing a copy of MAGEL2 have trouble discerning between a familiar mouse and an unfamiliar one; treating them with the social hormone vasopressin reverses this deficit.
Vasopressin relieves social deficits in an autism mouse model
Mice missing a copy of MAGEL2 have trouble discerning between a familiar mouse and an unfamiliar one; treating them with the social hormone vasopressin reverses this deficit.
Brain-body connection may ease autistic people’s social problems
An auditory therapy may improve autistic people's emotional control and help them feel safe enough to engage with the world.
Brain-body connection may ease autistic people’s social problems
An auditory therapy may improve autistic people's emotional control and help them feel safe enough to engage with the world.
Explore more from The Transmitter
Early experience reshapes zebrafish retinal cells, alters behavior
The cells undergo a classic form of plasticity previously thought to occur only in downstream visual circuits.
Early experience reshapes zebrafish retinal cells, alters behavior
The cells undergo a classic form of plasticity previously thought to occur only in downstream visual circuits.
Loss of interneuron plasticity may be shared hallmark of neurodevelopmental conditions
Restoring an experience-dependent interneuron plasticity gene in adulthood improves memory and cuts seizures in CNTNAP2 knockout mice, a new study shows.
Loss of interneuron plasticity may be shared hallmark of neurodevelopmental conditions
Restoring an experience-dependent interneuron plasticity gene in adulthood improves memory and cuts seizures in CNTNAP2 knockout mice, a new study shows.
Neuropsychiatric MRI brain signatures fail reproducibility test
Small neuroimaging studies are unlikely to capture consistent anatomical changes related to conditions such as autism, schizophrenia and mood disorders, according to a new “wake-up call” study.
Neuropsychiatric MRI brain signatures fail reproducibility test
Small neuroimaging studies are unlikely to capture consistent anatomical changes related to conditions such as autism, schizophrenia and mood disorders, according to a new “wake-up call” study.